Health Canada

This page shows the latest Health Canada news and features for those working in and with pharma, biotech and healthcare.

EMA starts rapid review of Shire’s HAE antibody

Lanadelumab (SHP643) is also being assessed by Health Canada under a priority review application, and was submitted to the FDA last month.

Not in my backyard

And then after two years of doing this from Canada, the Secretary of Health and Human Services would have the authority to permit importation from countries in the Organisation for Economic ... And if 40% of US prescriptions flow through Canada, the
Sanofi/Regeneron bag first approval for Actemra rival sarilumab

Sanofi/Regeneron bag first approval for Actemra rival sarilumab. Competition to Roche’ s blockbuster RA therapy heats up as Canada is first to licence new drug. ... Health Canada has given a green light to the interleukin-6 inhibitor - under the
Merck buys rights to NewLink’s Ebola vaccine

Merck will gain exclusive rights to rVSV-EBOV, a vaccine candidate originally developed by the Public Health Agency of Canada (PHAC) that is currently in phase I clinical trials to prevent ... Additional phase I studies are planned to take place in
Controversial pancreatic cancer campaign wins award

Health Last campaign for the Heart and Stroke Foundation of Canada. ... Make Health Last, Heart and Stroke Foundation of Canada by Lowe Roche (Canada).
Trials of NewLink's Ebola vaccine 'imminent'

An experimental Ebola vaccine developed by US company NewLink Genetics will start clinical trials within the next few days, according to the World Health Organisation (WHO). ... The NewLink vaccine - based on a weakened vesicular stomatitis virus (VSV) -

More from news
Approximately 2 fully matching, plus 38 partially matching documents found.

Gathering pace: adaptive pathways

Canada has also been developing the concept under the banner of 'progressive licensing'. ... and Finn Børlum-Kristensen from the European network for health technology assessment and Danish Health and Medicines Authority.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Kite Pharma appoints head of regulatory affairs

international agencies – FDA, EMA/CHMP, Health Canada, and PMDA – at multiple levels will be critical to Kite's further advancement and planning.”.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Add my company

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Pharma’s isolated islands of innovation: With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit: What does it mean for the life science sector?...
The Holy Grail of HCP Access: This is the data you need to gain access....